Depression Clinical Trials in Los Angeles

Showing 41-60 of 231 trials

Intermittent Theta Burst Stimulation for MDD

NCT02506127

This study will evaluate the effectiveness of intermittent Theta Burst Stimulation for patients with Major Depressive Disorder.

Major Depressive Disorder

University of California, Los Angeles30 participantsStarted Dec 2017

Los Angeles, California, United States

COMPLETEDNA< 1 mile

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

NCT04279522

The MOOD study will evaluate the safety and efficacy of a noninvasive, self-administered external Combined Occipital and Trigeminal Neurostimulation (eCOT-NS) treatment for Major Depressive Disorder (Relivion®DP). This is a prospective, multi-center, 2-arm randomized, double-blind, parallel-group, sham-controlled study. The study will include the following stages: 1. Screening, Eligibility evaluation and Randomization to Relivion®DP vs. Sham control (1:1 randomization) (Baseline - Day 0). 2. Daily treatment period: Active/Sham (Group A/B) treatment protocol (Baseline to end of 8 weeks). 3. Open label phase: Active treatment period of additional 8 weeks. After completion of the open label period the subject's participation in the study will be over.

MDD

Neurolief Ltd.124 participantsStarted Aug 2021

La Jolla, California, United States • Los Angeles, California, United States • Miami Lakes, Florida, United States +10 more locations

Intermittent Theta Burst Stimulation for MDD

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Depression Trials in Other Cities

HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression

Affect Treatment for Depression and Anxiety (TAD Pilot)

Virtual Reality-Reward Training for Anhedonia

Intergenerational Transmission of Traumatic Stress

A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

Improving Depression Management

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)

A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

ANC-501 in the Treatment of Adults With Major Depressive Disorder

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

Phase 2b Study of ALTO-100 in MDD

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Other Conditions in Los Angeles